| Primary |
| Self-medication |
40.0% |
| Drug Use For Unknown Indication |
20.0% |
| Immune Enhancement Therapy |
20.0% |
| Retinitis Pigmentosa |
20.0% |
|
| Aspartate Aminotransferase Increased |
20.0% |
| Liver Transplant |
20.0% |
| Lung Neoplasm |
20.0% |
| Splenomegaly |
20.0% |
| Urinary Tract Infection Staphylococcal |
20.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
39.6% |
| Product Used For Unknown Indication |
9.0% |
| Crohn's Disease |
7.1% |
| Sleep Disorder |
6.1% |
| Eating Disorder |
5.7% |
| Hypovitaminosis |
5.7% |
| Foreign Body In Eye |
3.8% |
| Anxiety |
2.8% |
| Depression |
2.8% |
| Pyelonephritis |
2.4% |
| Hiv Infection |
1.9% |
| Pain In Extremity |
1.9% |
| Palpitations |
1.9% |
| Restless Legs Syndrome |
1.9% |
| Acne |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Depressive Symptom |
1.4% |
| Neuropathy Peripheral |
1.4% |
| Back Pain |
0.9% |
| Intervertebral Disc Degeneration |
0.9% |
|
| Febrile Convulsion |
11.8% |
| Tubulointerstitial Nephritis |
11.8% |
| Vomiting |
11.8% |
| Femur Fracture |
5.9% |
| Mania |
5.9% |
| Rash |
5.9% |
| Tremor |
5.9% |
| Vitamin B12 Deficiency |
5.9% |
| Blindness |
2.9% |
| Constipation |
2.9% |
| Death |
2.9% |
| Dehydration |
2.9% |
| Dizziness |
2.9% |
| Generalised Oedema |
2.9% |
| Henoch-schonlein Purpura |
2.9% |
| Hydrocephalus |
2.9% |
| Ill-defined Disorder |
2.9% |
| Intentional Drug Misuse |
2.9% |
| Ocular Hyperaemia |
2.9% |
| Pain In Extremity |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.1% |
| Drug Use For Unknown Indication |
14.9% |
| Supplementation Therapy |
4.7% |
| Hypertension |
4.5% |
| Osteoporosis |
3.6% |
| Pain |
3.5% |
| Rheumatoid Arthritis |
3.4% |
| Vitamin Supplementation |
3.0% |
| Crohn's Disease |
2.7% |
| Paroxysmal Nocturnal Haemoglobinuria |
2.6% |
| Prophylaxis |
2.6% |
| Diabetes Mellitus |
2.4% |
| Depression |
2.1% |
| Cystic Fibrosis |
2.0% |
| Multiple Sclerosis |
1.8% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Insomnia |
1.7% |
| Psoriasis |
1.7% |
| Type 2 Diabetes Mellitus |
1.6% |
| Blood Cholesterol Increased |
1.6% |
|
| Weight Decreased |
16.3% |
| Vomiting |
10.5% |
| Pneumonia |
6.6% |
| Drug Ineffective |
5.3% |
| Weight Increased |
5.3% |
| Pyrexia |
4.7% |
| Nausea |
4.2% |
| Pruritus |
4.2% |
| Visual Acuity Reduced |
4.2% |
| Pain In Extremity |
3.9% |
| Vision Blurred |
3.9% |
| White Blood Cell Count Decreased |
3.9% |
| Death |
3.7% |
| Renal Failure |
3.7% |
| Diarrhoea |
3.4% |
| Pain |
3.4% |
| Arthralgia |
3.2% |
| Fatigue |
3.2% |
| Flushing |
3.2% |
| Muscle Spasms |
3.2% |
|
| Interacting |
| Lung Neoplasm Malignant |
100.0% |
|
| Visual Impairment |
85.7% |
| Performance Status Decreased |
14.3% |
|
